retatrutide phase 2 results 2024 2025 press release Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide—A Game Changer in Obesity

This lack of transparency undermines trust in the models results and limits its adoption in clinical practice

A truncated 67-aa IGF-1 analog lacking the N-terminal Gly-Pro-Glu tripeptide, with higher intrinsic IGF-1R affinity and moderately reduced IGFBP binding

These salt forms of GLP-1s have not been proven safe and effective in humans or approved by the FDA, Basina noted, adding that effectiveness can be different due to the salt form differences. Additives To differentiate their products from the FDA-approved GLP-1s, many compounders add extra ingredients most commonly vitamin B12, but also B6, niacinamide, glycine or carnitine that have no proven benefit for weight loss or diabetes management

Havent quite found what you are looking for

Learn whether a GLP-1 medication could be a safe, effective option for you through a short medical assessment